In the realm of diabetes management, two innovative medications have emerged as frontrunners: tirzepatide and semaglutide. Both therapies act on distinct receptors within the body to manage blood sugar levels, offering promising outcomes for individuals with type 2 diabetes. Yet, these medications exhibit significant differences in their mechanisms

In the realm of diabetes management, two innovative medications have emerged as frontrunners: tirzepatide and semaglutide. Both therapies act on distinct receptors within the body to control blood sugar levels, offering promising results for individuals with type 2 diabetes. Yet, these medications exhibit subtle differences in their mechanisms of a